Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
AHCO

AHCO - AdaptHealth Corp Stock Price, Fair Value and News

11.26USD-0.05 (-0.44%)Market Closed

Market Summary

AHCO
USD11.26-0.05
Market Closed
-0.44%

AHCO Stock Price

View Fullscreen

AHCO RSI Chart

AHCO Valuation

Market Cap

1.5B

Price/Earnings (Trailing)

-2.15

Price/Sales (Trailing)

0.46

EV/EBITDA

-16.23

Price/Free Cashflow

28.18

AHCO Price/Sales (Trailing)

AHCO Profitability

EBT Margin

-22.57%

Return on Equity

-47.63%

Return on Assets

-15.46%

Free Cashflow Yield

3.55%

AHCO Fundamentals

AHCO Revenue

Revenue (TTM)

3.2B

Rev. Growth (Yr)

6.43%

Rev. Growth (Qtr)

-7.66%

AHCO Earnings

Earnings (TTM)

-696.2M

Earnings Growth (Yr)

-113.59%

Earnings Growth (Qtr)

99.16%

Breaking Down AHCO Revenue

Last 7 days

15.5%

Last 30 days

-0.2%

Last 90 days

20.3%

Trailing 12 Months

-22.1%

How does AHCO drawdown profile look like?

AHCO Financial Health

Current Ratio

1.33

Debt/Equity

1.48

Debt/Cashflow

0.18

AHCO Investor Care

Buy Backs (1Y)

0.72%

Diluted EPS (TTM)

-5.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20243.2B000
20233.0B3.1B3.1B3.2B
20222.7B2.8B2.9B3.0B
20211.3B1.7B2.1B2.5B
2020601.6M709.5M857.5M1.1B
2019391.4M437.5M483.6M529.6M
2018000345.3M

Tracking the Latest Insider Buys and Sells of AdaptHealth Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 24, 2024
williams david solomon iii
acquired
-
-
15,629
-
Jun 24, 2024
weaver susan t
acquired
-
-
15,629
-
Jun 24, 2024
connors terence j
acquired
-
-
15,629
-
Jun 24, 2024
belinfanti gregory
acquired
-
-
15,629
-
Jun 24, 2024
lundberg theodore b.
acquired
-
-
17,523
-
Jun 24, 2024
coppens bradley j
acquired
-
-
17,523
-
Jun 24, 2024
wolf dale b
acquired
-
-
25,101
-
Jun 18, 2024
barasch richard a
sold (taxes)
-35,198
9.89
-3,559
-
Jun 11, 2024
lundberg theodore b.
sold
-
-
-2,027,500
-
Jun 11, 2024
peloton equity gp, llc
sold
-
-
-2,027,500
-

1–10 of 50

Which funds bought or sold AHCO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 12, 2024
INSPIRION WEALTH ADVISORS, LLC
unchanged
-
-185,523
1,228,630
0.19%
Jul 12, 2024
SG Americas Securities, LLC
added
0.78
-16,000
113,000
-%
Jul 12, 2024
LGT CAPITAL PARTNERS LTD.
reduced
-66.84
-7,784,500
3,150,000
0.11%
Jul 10, 2024
Fiduciary Alliance LLC
reduced
-62.5
-311,637
154,294
0.03%
Jul 10, 2024
CWM, LLC
added
40.87
6,000
29,000
-%
Jul 10, 2024
Simplicity Wealth,LLC
unchanged
-
-52,306
346,400
0.01%
Jul 09, 2024
HARBOR CAPITAL ADVISORS, INC.
added
289
1,305,000
1,852,000
0.14%
Jul 08, 2024
Versant Capital Management, Inc
added
23.63
484
7,010
-%
Jul 03, 2024
EVERENCE CAPITAL MANAGEMENT INC
unchanged
-
-44,000
258,000
0.02%
Jul 03, 2024
MOODY NATIONAL BANK TRUST DIVISION
added
29.56
91,025
815,510
0.06%

1–10 of 45

Are Funds Buying or Selling AHCO?

Are funds buying AHCO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AHCO
No. of Funds

Unveiling AdaptHealth Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jun 11, 2024
everest hill group inc.
6.06%
8,069,508
SC 13D/A
Feb 13, 2024
vanguard group inc
6.75%
9,199,481
SC 13G/A
Feb 12, 2024
flynn james e
8.71%
13,674,318
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 08, 2024
blackrock inc.
10.3%
14,066,565
SC 13G/A
Aug 28, 2023
everest hill group inc.
7.14%
9,721,412
SC 13D/A
Aug 11, 2023
peloton equity aerocare spv i, l.p.
1.6%
2,220,277
SC 13D/A
May 16, 2023
peloton equity aerocare spv i, l.p.
3.3%
4,460,555
SC 13D/A
Feb 10, 2023
flynn james e
4.9%
7,693,292
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G

Recent SEC filings of AdaptHealth Corp

View All Filings
Date Filed Form Type Document
Jul 03, 2024
8-K
Current Report
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 26, 2024
4
Insider Trading
Jun 24, 2024
4
Insider Trading
Jun 21, 2024
8-K
Current Report

Peers (Alternatives to AdaptHealth Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
182.2B
40.3B
1.20% -2.11%
32.36
4.52
-2.84% -3.00%
67.6B
19.7B
0.55% -8.69%
50.74
3.43
4.82% -17.56%
18.9B
3.9B
2.12% -30.48%
40.83
4.82
5.72% 46.72%
18.2B
14.9B
5.25% -24.14%
6.87
1.22
2.98% 207.68%
MID-CAP
9.6B
3.5B
-1.00% 21.66%
30.69
2.71
6.16% 35.06%
9.1B
12.4B
7.63% -10.11%
23.51
0.73
-0.93% -18.83%
9.1B
2.6B
7.84% -17.07%
-28.21
3.49
-6.25% -68.58%
5.7B
3.9B
7.40% -32.03%
-59.92
1.45
0.23% 90.80%
3.5B
387.1M
1.13% 33.46%
-217.87
8.97
30.82% 65.57%
2.3B
6.6B
15.49% -18.17%
12.46
0.35
1.50% -10.09%
SMALL-CAP
1.5B
3.2B
-0.18% -22.08%
-2.15
0.46
7.94% -1695.32%
426.8M
169.3M
10.73% 14.84%
-5.55
2.52
7.49% -244.90%
296.4M
324.0M
25.64% -24.02%
-1.54
0.91
-3.19% -337.41%
47.1M
50.5M
-7.48% -77.96%
-2.07
0.93
14.25% -10.06%
6.0M
3.5M
-32.81% -89.76%
-0.49
1.69
-0.62% -1.48%

AdaptHealth Corp News

Latest updates
Defense World24 hours ago
Yahoo Finance12 Jul 202401:13 pm
MarketBeat01 Jul 202408:32 am

AdaptHealth Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-7.7%792858804793745780756728706702653617482348284232191150136124119
Costs and Expenses-31.0%7421,0761,265739718754704668655644578552467328271217183149128109114
  S&GA Expenses2.3%48.0047.0045.0050.0048.0037.0041.0043.0041.0035.0033.0043.0057.0032.0026.0017.0014.0025.0012.006.0013.00
EBITDA Margin-3.1%-0.07*-0.07*0.02*0.19*0.18*0.19*0.19*0.21*0.24*0.22*0.17*0.09*---------
Interest Expenses-3.0%32.0033.0032.0033.0032.0031.0029.0026.0025.0026.0024.0023.0022.0014.0012.007.008.008.0011.0015.006.00
Income Taxes136.5%7.00-18.10-34.605.00-1.715.006.009.006.0010.0012.0012.00-1.69-7.22-4.902.00-1.64-4.701.002.002.00
Earnings Before Taxes102.0%6.00-271-48720.0015.003.0023.0024.0048.0033.0070.0092.00-5.34-97.73-66.9010.00-51.09-17.07-2.030.00-3.03
EBT Margin0.2%-0.23*-0.23*-0.14*0.02*0.02*0.03*0.04*0.06*0.09*0.08*0.03*-0.04*---------
Net Income99.2%-2.13-255-45415.0016.00-3.4416.0015.0042.0022.0058.0080.00-3.64-74.76-51.038.00-49.45-10.13-3.69-1.72-5.45
Net Income Margin-1.1%-0.21*-0.21*-0.14*0.01*0.01*0.02*0.03*0.05*0.08*0.06*0.03*-0.03*---------
Free Cashflow-158.3%-38.8667.0022.004.0051.00-45.9913.0026.00-10.7137.00-33.1685.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-0.1%4,5044,5094,7255,2035,2835,2205,2385,2025,2045,2505,1924,6884,5201,8131,556742665547257256255
  Current Assets1.1%6566495855686475856326056156708235915043634842641951811.001.001.00
    Cash Equivalents3.2%80.0077.0056.0045.0010146.0011111911915033717813210027211148.0077.009.002.0015.00
  Inventory-4.4%10911411611513612812510310012310082.0075.0059.0046.0024.0018.0013.00---
  Net PPE1.4%502495----47345542539934130929911010283.0087.0064.00---
  Goodwill-0.2%2,7182,7253,0413,5520.003,54512.005.002.003,51363.0046.0040.0099936.0050.001.0026744.00--
Liabilities-0.3%3,0333,0422,9853,0163,1163,0623,0783,0643,0843,1843,1972,7942,7281,5331,2118147656124112109.00
  Current Liabilities-8.3%4935374484585244564674354445005026065134223152571911543.002.001.00
  Long Term Debt3.1%2,1592,0952,1272,1362,1692,1532,1622,1712,1802,1842,1871,7761,749777723443464395---
    LT Debt, Current-25.0%40.0053.0040.0040.0040.0035.0030.0025.0020.0020.0020.0097.0018.008.008.003.003.002.00---
    LT Debt, Non Current3.1%2,1592,0952,1272,1362,1692,1532,1622,1712,1802,1842,1871,7761,749777723443464395---
Shareholder's Equity0.2%1,4621,4581,7322,1872,1672,1582,1602,1382,1212,0671,9941,8941,7922813158.00--5.005.005.00
  Retained Earnings-0.3%-654-652-39856.0042.0026.0029.0013.00-1.27-43.02-65.96-124-203-199-118-70.34-74.81-40.262.002.003.00
  Additional Paid-In Capital0.2%2,1552,1502,1452,1402,1352,1302,1262,1192,1132,1072,0572,0161,99455848517.0026.004.003.003.002.00
Shares Outstanding0.4%133133135135135134134134134126132130---------
Minority Interest12.5%9.008.007.006.008.007.006.004.005.005.004.004.004.00-74.04-45.83-42.59-46.35-26.96---
Float----1,260---1,510---2,170---185---253-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-68.4%49,035155,26698,83386,319140,24896,920107,023103,47366,451100,92927,126129,24418,38050,34734,27986,62824,38017,24417,1389,80416,232
  Share Based Compensation-12.6%4,5335,1844,5216,8475,9165,6135,5625,7205,5023,9295,3657,4478,5827,7015,5023,2442,2235,2644001835,223
Cashflow From Investing2.8%-87,891-90,417-77,098-100,196-89,567-145,795-95,345-89,933-80,098-266,246-186,480-158,263-1,213,764-188,606-509,765-6,003-111,329-22,471-23,689-12,530-26,179
Cashflow From Financing194.1%41,290-43,860-10,718-42,3984,448-15,591-19,749-14,159-16,552-21,710317,81975,0711,227,559-34,097637,217-18,20258,23573,28213,215-9,984-368
  Buy Backs-100.0%-20,051--9,224-10,6173,375-------------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

AHCO Income Statement

2024-03-31
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Net revenue$ 792,497$ 744,626
Revenue, Product and Service [Extensible Enumeration]Health Care, Patient Service [Member]Health Care, Patient Service [Member]
Costs and expenses:  
Cost of net revenue$ 675,693$ 655,396
Cost, Product and Service [Extensible Enumeration]Health Care, Patient Service [Member]Health Care, Patient Service [Member]
General and administrative expenses$ 48,378$ 47,521
Depreciation and amortization, excluding patient equipment depreciation11,36515,532
Goodwill impairment (note 5)6,5300
Total costs and expenses741,966718,449
Operating income50,53126,177
Interest expense, net32,47231,955
Change in fair value of warrant liability (note 10)7,453(21,914)
Other loss, net5,1051,175
Income before income taxes5,50114,961
Income tax expense (benefit)6,610(1,714)
Net (loss) income(1,109)16,675
Income attributable to noncontrolling interest1,025968
Net (loss) income attributable to AdaptHealth Corp.$ (2,134)$ 15,707
Weighted average common shares outstanding - basic (in shares)132,914134,525
Weighted average common shares outstanding - diluted (in shares)132,914135,976
Basic net (loss) income per share (note 11) (in dollars per share)$ (0.02)$ 0.11
Diluted net loss per share (note 11) (in dollars per share)$ (0.02)$ (0.06)

AHCO Balance Sheet

2024-03-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash$ 79,566$ 77,132
Accounts receivable429,558388,910
Inventory108,585113,642
Prepaid and other current assets38,27269,338
Total current assets655,981649,022
Equipment and other fixed assets, net501,892495,101
Operating lease right-of-use assets111,232110,465
Finance lease right-of-use assets30,42731,962
Goodwill2,718,4282,724,958
Identifiable intangible assets, net124,591130,160
Other assets20,00121,128
Deferred tax assets341,141345,854
Total Assets4,503,6934,508,650
Current liabilities:  
Accounts payable and accrued expenses340,234391,994
Current portion of long-term debt40,00053,368
Current portion of operating lease obligations31,53029,270
Current portion of finance lease obligations9,2459,122
Contract liabilities34,04038,570
Warrant liability11,4744,021
Other liabilities26,16910,654
Total current liabilities492,692536,999
Long-term debt, less current portion2,159,1612,094,614
Operating lease obligations, less current portion84,11585,529
Finance lease obligations, less current portion21,05722,746
Other long-term liabilities275,639302,093
Total Liabilities3,032,6643,041,981
Commitments and contingencies (note 14)
Stockholders' Equity:  
Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized; 133,194,999 and 132,634,850 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively1313
Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of March 31, 2024 and December 31, 202311
Treasury stock, at cost (3,935,035 shares at March 31, 2024 and December 31, 2023)(43,267)(43,267)
Additional paid-in capital2,154,5642,149,951
Accumulated deficit(654,734)(652,600)
Accumulated other comprehensive income5,2124,356
Total stockholders' equity attributable to AdaptHealth Corp.1,461,7891,458,454
Noncontrolling interest in subsidiary9,2408,215
Total Stockholders' Equity1,471,0291,466,669
Total Liabilities and Stockholders' Equity$ 4,503,693$ 4,508,650
AHCO
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
 WEBSITEhttps://adapthealth.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES10900

AdaptHealth Corp Frequently Asked Questions


What is the ticker symbol for AdaptHealth Corp? What does AHCO stand for in stocks?

AHCO is the stock ticker symbol of AdaptHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AdaptHealth Corp (AHCO)?

As of Wed Jul 17 2024, market cap of AdaptHealth Corp is 1.5 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers. The fair value of AdaptHealth Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of AdaptHealth Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AHCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is AdaptHealth Corp a good stock to buy?

The fair value guage provides a quick view whether AHCO is over valued or under valued. Whether AdaptHealth Corp is cheap or expensive depends on the assumptions which impact AdaptHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AHCO.

What is AdaptHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jul 17 2024, AHCO's PE ratio (Price to Earnings) is -2.15 and Price to Sales (PS) ratio is 0.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AHCO PE ratio will change depending on the future growth rate expectations of investors.